Simon Giroux

This inventor holds 30 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Giroux. Retrieved from https://idiyas.com/inventor/simon-giroux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 17)

% Patents Active = 93.3

CIPO Patents = 4 (Patent Applications = 13)

EPO Patents = 9 (Patent Applications = 23)

Average Co-Inventor Count = 13.8

ph-index = 7

Forward Citations = 211(Granted Patents)

Company Filing History:

30 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Alpha-1-Antitrypsin

DNA-PK Inhibitors

Quinoxaline Derivatives

Flavivirus Infections

Benzimidazole Analogues

Isoquinoline Derivatives

Indole Derivatives

Gyrase Inhibitors

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662471 - 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-06-23),

2. 12624028 - 1H-pyrazolo[4,3-G]isoquinoline and 1H-pyrazolo[4,3-g]quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2026-05-12),

3. 12502376 - Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD) (2025-12-23),

4. 12331057 - Modulators of alpha-1 antitrypsin (2025-06-17),

5. 12251387 - Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors (2025-03-18),

6. 11884672 - Modulators of alpha-1 antitrypsin (2024-01-30),

7. 11813267 - DNA-PK inhibitors (2023-11-14),

8. 11623924 - Modulators of alpha-1 antitrypsin (2023-04-11),

9. 11021465 - DNA-PK inhibitors (2021-06-01),

10. 11008305 - DNA-PK inhibitors (2021-05-18),

11. 10973830 - Substituted quinoxaline DNA-PK inhibitors (2021-04-13),

12. 10786512 - DNA-PK inhibitors (2020-09-29),

13. 10501439 - DNA-PK inhibitors (2019-12-10),

14. 10442791 - DNA-PK inhibitors (2019-10-15),

15. 10391095 - DNA-PK inhibitors (2019-08-27),

Title: The Innovative Journey of Simon Giroux

Introduction: Simon Giroux is a visionary inventor based in Cambridge, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Simon Giroux holds several patents in the areas of renewable energy, artificial intelligence, and biotechnology, showcasing his diverse range of expertise.

Career Highlights: With a background in engineering and a passion for problem-solving, Simon Giroux has led numerous successful projects that have revolutionized industries and improved people's lives.

Collaborations: Throughout his career, Simon Giroux has collaborated with leading researchers, engineers, and scientists from prestigious institutions to bring his innovative ideas to life.

Conclusion: Simon Giroux's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.